RNS Number : 6796M
Chrysalis Investments Limited
19 November 2024
 

 

 

 

19 November 2024

 

 

Chrysalis Investments Limited ("Chrysalis" or the "Company")

 

Transaction in own shares

 

 

The Company announces that, in accordance with the terms of its share buyback programme (the "Programme") announced on 26 September 2024, it has repurchased the following number of its ordinary shares through Panmure Liberum.

 



Date of Purchase

18 November 2024

Number of ordinary shares purchased

400,000

Weighted average price paid (£)

0.9525

 

All Ordinary Shares purchased will be held in treasury. Following the above purchase, the Company holds 14,516,278 Ordinary Shares in treasury.

 

The total number of Ordinary Shares in issue excluding shares held as treasury shares is 580,634,136. 

 

The above figure of 580,634,136 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Correction to previous announcements

 

On the dates below the number of shares held in treasury were incorrectly stated in the announcements made by the Company. A correction to the number of shares held in treasury on those dates is included below:

 





Date of announcement

Date of buyback

Ordinary shares in treasury

(originally stated)

Ordinary shares in treasury (corrected)

18 November 2024

15 November 2024

 13,858,816

 14,116,278

14 November 2024

13 November 2024

 13,208,816

 13,466,278

 

 

 

 

-ENDS-

 

 

 

 

 

For further information, please contact

 

Media

Montfort Communications:

Charlotte McMullen / Imogen Saunders

 

 

 

 

 

 

+44 (0) 7921 881 800

chrysalis@montfort.london

 

 

Investment Adviser

Chrysalis Investment Partners LLP:

James Simpson

 

+44 (0) 20 7871 5343

G10 Capital Limited (AIFM):

+44 (0) 20 7397 5450

Maria Baldwin

 

 

 

Panmure Liberum:

Chris Clarke / Darren Vickers

 

+44 (0) 20 3100 2222

Deutsche Numis:

Nathan Brown / Matt Goss

 

+44 (0) 20 7260 1000

IQEQ Fund Services (Guernsey) Limited:

Aimee Gontier / Elaine Smeja

+44 (0) 1481 231852

 

LEI: 213800F9SQ753JQHSW24

 

A copy of this announcement will be available on the Company's website at https://www.chrysalisinvestments.co.uk

The information contained in this announcement regarding the Company's investments has been provided by the relevant underlying portfolio company and has not been independently verified by the Company. The information contained herein is unaudited.

This announcement is for information purposes only and is not an offer to invest. All investments are subject to risk. Past performance is no guarantee of future returns. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision. The value of investments may fluctuate. Results achieved in the past are no guarantee of future results. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

The Company is an alternative investment fund ("AIF") for the purposes of the AIFM Directive and as such is required to have an investment manager who is duly authorised to undertake the role of an alternative investment fund manager ("AIFM"). The AIFM appointed is G10 Capital Limited (part of the IQEQ Group).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSQVLFFZFLEFBX